Skip to main content
Emtricitabine/Tenofovir disoproxil Dr. Reddy's 200 mg/245 mg Film-Coated Tablets
For Healthcare Professionals
Renal and bone effects risk minimisation material: Tenofovir disoproxil for children and adolescents with HIV-1
Back to top
Risk Minimisation Materials
Search by company, common medicine name, or title of Risk Minimisation Material
Emtricitabine+Tenofovir
Dr. Reddy's Laboratories (UK) Ltd
For Healthcare Professionals
Checklist for Prescribers v2 Tenofovir PrEP
For Healthcare Professionals
Initiation of emtricitabine/tenofovir disoproxil for Pre-Exposure Prophylaxis (PrEP) Complete checklist at each visit and file in individuals medical record.
Important Information about Emtricitabine/Tenofovir Disoproxil To Reduce The Risk Of Getting Human Immunodeficiency Virus (HIV) Infection
Information for individuals who have been prescribed emtricitabine/tenofovir disoproxil for Pre-Exposure Prophylaxis (PrEP)
Important Safety Information for prescribers v2 Tenofovir PrEP
For Healthcare Professionals
Emtricitabine/ tenofovir disoproxil is indicated in combination with safer sex practices for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 infection in adults at high risk. This indication is based on clinical trials in men who have sex with men (MSM) at high risk for HIV-1 infection and on men and women in heterosexual serodiscordant couples.
Reminder Card v2 Tenofovir PrEP
You have been prescribed emtricitabine/ tenofovir disoproxil for PrEP (pre-exposure prophylaxis) to help reduce the risk of getting HIV-1 infection. For this medicine to work effectively it is important that you don’t miss doses. The recommended dose is one emtricitabine/ tenofovir disoproxil tablet each day. Take emtricitabine/ tenofovir disoproxil exactly as your doctor has told you.
Lupin Healthcare (UK) Ltd
Checklist for Prescribers
For Healthcare Professionals
Initiation of emtricitabine/tenofovir disoproxil for Pre-Exposure Prophylaxis (PrEP)
Important Information about Emticitabine/Tenofovir Disproxil
For Healthcare Professionals
Information for individuals who have been prescribed emtricitabine/ tenofovir disoproxil for Pre-Exposure Prophylaxis (PrEP)
Important Safety Information for Prescribers
For Healthcare Professionals
For Prescribers About emtricitabine/ tenofovir disoproxil for a Pre-Exposure Prophylaxis (PrEP) Indication
Reminder Card
For Healthcare Professionals
EMTRICITABINE/ TENOFOVIR DISOPROXIL FOR PrEP REMINDER CARD
Tillomed Laboratories Ltd
Important educational information for patients
Information for individuals who have been prescribed emtricitabine/ tenofovir disoproxil for Pre-Exposure Prophylaxis (PrEP)
Important safety information for prescribers
For Healthcare Professionals
For Prescribers About emtricitabine/ tenofovir disoproxil for a Pre-Exposure Prophylaxis (PrEP) Indication
Amarox Limited
CHECKLIST FOR PRESCRIBERS
For Healthcare Professionals
CHECKLIST FOR PRESCRIBERS Initiation of emtricitabine/tenofovir disoproxil for Pre-Exposure Prophylaxis (PrEP)
EMTRICITABINE/ TENOFOVIR DISOPROXIL FOR PrEP REMINDER CARD
EMTRICITABINE/ TENOFOVIR DISOPROXIL FOR PrEP REMINDER CARD
IMPORTANT SAFETY INFORMATION For Prescribers
For Healthcare Professionals
IMPORTANT SAFETY INFORMATION For Prescribers About emtricitabine/ tenofovir disoproxil for a Pre-Exposure Prophylaxis (PrEP) Indication
Information for individuals
IMPORTANT INFORMATION ABOUT EMTRICITABINE/TENOFOVIR DISOPROXIL TO REDUCE THE RISK OF GETTING HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION Information for individuals who have been prescribed emtricitabine/ tenofovir disoproxil for Pre-Exposure Prophylaxis (PrEP)
ADVANZ Pharma
Checklist for Prescribers v2 Tenofovir PrEP
For Healthcare Professionals
Checklist for Prescribers v2 Tenofovir PrEP
Important safety information for individuals using PrEP v2
For Healthcare Professionals
Important safety information for individuals using PrEP v2
Important safety information for prescribers v2 Tenofovir PrEP
For Healthcare Professionals
Important safety information for prescribers v2 Tenofovir PrEP
Tenofovir HBV indications materials for children and adolescents
For Healthcare Professionals
Tenofovir HBV indications materials for children and adolescents
Tenofovir HIV indications materials for children and adolescents
For Healthcare Professionals
Tenofovir HIV indications materials for children and adolescents
Mylan
Emtricitabine/Tenofovir disoproxil Checklist for Prescribers
For Healthcare Professionals
Emtricitabine/Tenofovir disoproxil Checklist for Prescribers PrEP
Emtricitabine/Tenofovir Disoproxil Patient Brochure
Patient Brochure for Emtricitabine/Tenofovir disoproxil for PrEP (pre-exposure prophylaxis)
Emtricitabine/Tenofovir Disoproxil Prescriber's Brochure
For Healthcare Professionals
Important Safety Information for Prescribers About Emtricitabine/Tenofovir Disoproxil for a Pre-exposure Prophylaxis (PrEP) Indication
Patient Reminder Card for Emtricitabine/Tenofovir Disoproxil
Patient Reminder Card for Emtricitabine/Tenofovir disoproxil for PrEP (pre-exposure prophylaxis).
Aurobindo Pharma - Milpharm Ltd.
Emtricitabine-Tenofovir Checklist for Prescribers
For Healthcare Professionals
Emtricitabine-Tenofovir Checklist for Prescribers-v2.0
Emtricitabine-Tenofovir Important educational information for Patients
For Healthcare Professionals
Important educational information for Patients
Emtricitabine-Tenofovir Important safety information for prescribers
For Healthcare Professionals
Important safety information for prescribers-v2.0
Emtricitabine-Tenofovir Patient Reminder card
For Healthcare Professionals
Patient Reminder card-v2.0
Tenofovir
Cipla EU Ltd
Educational Material: TENOFOVIR DISOPROXIL FOR ADOLESCENT CHILDREN WITH CHRONIC HEPATITIS B
For Healthcare Professionals
RENAL RISK MINIMISATION MATERIAL: TENOFOVIR DISOPROXIL FOR ADOLESCENT CHILDREN WITH CHRONIC HEPATITIS B
Educational material: TENOFOVIR DISOPROXIL FOR CHILDREN AND ADOLESCENTS WITH HIV-1
For Healthcare Professionals
RENAL AND BONE EFFECTS RISK MINIMISATION MATERIAL: TENOFOVIR DISOPROXIL FOR CHILDREN AND ADOLESCENTS WITH HIV-1
Dr. Reddy's Laboratories (UK) Ltd
Renal and Bone Effects Risk Minimisation Material: Tenofovir Disoproxil for Children and Adolescents with HIV-1
For Healthcare Professionals
HIV-1 Renal & bone effects education brochure - children
Renal Risk Minimisation Material Tenofovir Disoproxil for Adolescent Children with Chronic Hepatitis B
For Healthcare Professionals
HBV renal education brochure - children
Sandoz Limited
Renal and bone effects risk minimisation material: Tenofovir disoproxil for children and adolescents with HIV-1
For Healthcare Professionals
This brochure provides important advice on the management of potential renal and bone effects of tenofovir disoproxil in HIV-1 infected children and adolescents aged 2 to <18 years, and on the dosing recommendations for tenofovir disoproxil in this population.
Renal Risk Minimisation Material: Tenofovir Disoproxil for adolescent children with chronic hepatitis B
For Healthcare Professionals
This brochure provides important advice on the management of potential renal and bone effects of tenofovir disoproxil in adolescent patients with chronic hepatitis B aged 12 to <18 years, and on the dosing recommendations for tenofovir disoproxil in this population.
TENOFOVIR DISOPROXIL FOR ADULTS WITH CHRONIC HEPATITIS B
RENAL RISK MINIMISATION MATERIAL: TENOFOVIR DISOPROXIL FOR ADULTS WITH CHRONIC HEPATITIS B
Truvada
Gilead Sciences Ltd
Truvada 200 mg/245 mg film-coated tablets (emtricitabine/tenofovir disoproxil fumarate) - PrEP Educational Materials - Checklist For Prescribers
For Healthcare Professionals
Checklist For Prescribers from the Physician educational pack for Truvada® (emtricitabine 200mg/ tenofovir disoproxil fumarate 245mg) for pre-exposure prophylaxis (PrEP) in patients at risk of sexually acquired HIV-1 infection
Truvada 200 mg/245 mg film-coated tablets (emtricitabine/tenofovir disoproxil fumarate) - PrEP Educational Materials - Patient Leaflet
For Healthcare Professionals
Patient Leaflet from the Physician educational pack for Truvada® (emtricitabine 200mg/ tenofovir disoproxil fumarate 245mg) for pre-exposure prophylaxis (PrEP) in patients at risk of sexually acquired HIV-1 infection. It contains Important Information About Truvada® (emtricitabine/tenofovir disoproxil fumarate) to Reduce the Risk of Getting Human Immunodeficiency Virus (HIV) Infection for individuals who have been prescribed Truvada® for Pre-Exposure Prophylaxis (PrEP)
Truvada 200 mg/245 mg film-coated tablets (emtricitabine/tenofovir disoproxil fumarate) - PrEP Educational Materials - Prescribers Leaflet
For Healthcare Professionals
Important Safety Information for Prescribers About Truvada® (emtricitabine/tenofovir disoproxil fumarate) for a Pre-exposure Prophylaxis (PrEP) Indication
Truvada 200 mg/245 mg film-coated tablets (emtricitabine/tenofovir disoproxil fumarate) - PrEP Educational Materials - Reminder Card
For Healthcare Professionals
Reminder Card for patients from the Physician educational pack for Truvada® (emtricitabine 200mg/ tenofovir disoproxil fumarate 245mg) for pre-exposure prophylaxis (PrEP) in patients at risk of sexually acquired HIV-1 infection.
You are trying to reach document intended for healthcare professionals only.
Are you a healthcare professional?
